The Correlation Between Genetic Polymorphism, Platelet Activity, Clopidogrel Responsiveness, and Serum Adipokine Concentration in Asian Acute Coronary Syndrome Patients

Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 Polymorphism

NCT01012193 ·Status: COMPLETED ·Phase: PHASE4

Platelet Function Assessment for Atherothrombotic Patients

NCT00513149 ·Status: UNKNOWN ·Phase: PHASE4

Genotyping Guided Individualized Treatment of Clopidogrel and Ticagrelor in ACS

NCT02048228 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

The Relationship of Platelet Micro-RNA Expression and Platelet Reactivity in Patients Under Clopidogrel or Ticagrelor Treatment

NCT02101437 ·Status: COMPLETED ·Phase: NA

The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized and Cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction

NCT02411903 ·Status: UNKNOWN ·Phase: PHASE4

Personalized Antiplatelet Therapy in CAD Patients

NCT05174143 ·Status: COMPLETED

Clopidogrel Preventive Effect Based on CYP2C19 Genotype in Ischemic Stroke

NCT04072705 ·Status: COMPLETED

Genotyping Influences Outcome of Coronary Artery Stenting

NCT02707445 ·Status: COMPLETED ·Phase: NA

Optimal Regimen in Endovascular Therapy in Ischemic Cerebrovascular Disease Based on Clopidogrel Resistance

NCT01925872 ·Status: UNKNOWN

Pharmacogenetic and Pharmacokinetic Study of Clopidogrel

NCT01968499 ·Status: COMPLETED

Evaluation of the Efficacy of Novel Biomarkers in Predicting Clopidogrel Resistance in Patients with Ischemic Stroke

NCT06753149 ·Status: NOT_YET_RECRUITING

Biomarkers of Clopidogrel Resistance for Predicting Ischemic Recurrence After Cerebral Artery Stenting

NCT07028775 ·Status: NOT_YET_RECRUITING

Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients

NCT02459288 ·Status: UNKNOWN ·Phase: PHASE4

PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants

NCT01641510 ·Status: COMPLETED ·Phase: PHASE3

Comparison Of Efficacy and Safety Between Ticagrelor and Clopidogrel In Chinese

NCT03239067 ·Status: COMPLETED

Different Platelet Activities Between Intracoronary and Peripheral Blood in Coronary Artery Disease Patients

NCT03078257 ·Status: UNKNOWN ·Phase: PHASE1

Effect of Diabetes and Hepatic Enzymes Mutation on Clopidogrel VS Ticagrelor Activity in Myocardial Infarction (MI) Patients Undergoing Primary Percutaneous Coronary Intervention (PCI)

NCT03613857 ·Status: COMPLETED

CYP2C19 Gene Alteration and Thienopyridine Resistance in Percutaneous Coronary Intervention Study

NCT00876512 ·Status: COMPLETED

Clinical Significance of Platelet Reactivity on Clopidogrel During Off-pump Coronary Artery Bypass

NCT01959191 ·Status: COMPLETED

Genotype-guided Strategy for Antithrombotic Treatment in Peripheral Arterial Disease.

NCT04619927 ·Status: UNKNOWN ·Phase: PHASE4

Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention

NCT01505790 ·Status: COMPLETED ·Phase: PHASE3

Effect of Proton Pump Inhibitor on Residual Platelet Reactivity After Clopidogrel in Homogenous Genetic Strata

NCT01512953 ·Status: UNKNOWN ·Phase: PHASE4

Plasma and Platelet microRNAs in Clopidogrel Low Response Patients

NCT02447809 ·Status: UNKNOWN ·Phase: PHASE4

Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes

NCT02319941 ·Status: COMPLETED ·Phase: PHASE2

Clopidogrel Efficacy and Acute Coronary Syndromes

NCT00839267 ·Status: COMPLETED